S&P 500
5,930.21
-0.2%
-10.25
DJI
42,369.37
-0.7%
-307.87
NASDAQ
$19,204.06
+0.3%
+$61.34
Bitcoin
108,757.00
+3.9%
+4,080.37
AAPL
$206.62
-0.1%
-$0.24
AMZN
$202.78
-0.6%
-$1.29
GOOG
$174.08
+5.3%
+$8.76
META
$644.94
+1.2%
+$7.84
MSFT
$456.60
-0.3%
-$1.57
NVDA
$135.46
+0.8%
+$1.08
TSLA
$344.80
+0.3%
+$0.98
Mei Pharma (NASDAQ: MEIP)
$2.12
(1.9%)
$0.04
Price as of May 20, 2025, 10:23 a.m. ET
Mei Pharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Mei Pharma Company Info
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its products include Zandelisib, Voruciclib, and ME-344. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.
News & Analysis
Featured Article
Why MEI Pharma Is Tanking 15.3% Today
A trial evaluating its most advanced drug has been discontinued because of a lack of efficacy.
Todd Campbell | Jul 2, 2020
Featured Article
7 Surprising 1-Star Stocks
From the very depths of pessimism come some nice returns.
Matt Koppenheffer | Jan 16, 2007
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.